Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis

Published:2023-08-17 Issue:4 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Rollo Rachel F.¹^ORCID,Mori Giorgia¹^ORCID,Hill Timothy A.²³^ORCID,Hillemann Doris⁴,Niemann Stefan⁵⁶^ORCID,Homolka Susanne⁵^ORCID,Fairlie David P.²³^ORCID,Blumenthal Antje¹^ORCID

Affiliation:

1. Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia

2. Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia

3. Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia

4. National and WHO Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany

5. Molecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Borstel, Germany

6. German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany

Abstract

Tuberculosis (TB) is an infectious disease that affects millions of people globally, with 1.6 million deaths annually. TB treatment requires combinations of multiple different antibiotics for many months, and toxic side effects can occur.

Funder

U.S. Department of Defense

DHAC | National Health and Medical Research Council

Department of Education and Training | Australian Research Council

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00465-23

Reference72 articles.

1. World Health Organization (WHO). 2022. Global Tuberculosis Report 2022. WHO, Geneva, Switzerland.

2. Advances in the development of new tuberculosis drugs and treatment regimens

3. PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis

4. The End of the Binary Era: Revisiting the Spectrum of Tuberculosis

5. Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery